(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ARCUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ARCUS

ST13

US500000085529823

Class

42

Filing

85529823

Registration

4217046

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

01/16/2025

Trademark type

Word

Nice classes

42

Filing date

01/31/2012

Registration date

10/02/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/11/2023

Last transaction

01/16/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

11/29/2011

First use in commerce

11/29/2011

Drawing code

4

Owner type

16

Owner location

RALEIGH, NC

Examiner

LAPTER, ALAIN

Law office

L80

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

MERZ PHARMACEUTICALS, LLC
ACORDA THERAPEUTICS, INC.
C. T. (pessoa física)

Representatives

Joseph C. Guagliardo Dentons US LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceutical drug development servicesthe development of drug delivery devices and pharmaceutical products to the pulmonary system

Publications

History of USPTO decisions and trademark events.

37 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/15/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/11/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/11/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/11/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/11/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

09/30/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/02/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/02/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/02/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/02/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/02/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/02/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/13/2018

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/13/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/13/2018

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/03/2018

E815

TEAS SECTION 8 & 15 RECEIVED

10/02/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/02/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/02/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/02/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

10/02/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/17/2012

PUBO

PUBLISHED FOR OPPOSITION

07/17/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/27/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/12/2012

ALIE

ASSIGNED TO LIE

06/11/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/22/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/21/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/21/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/21/2012

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/10/2012

GNRT

NON-FINAL ACTION E-MAILED

05/10/2012

CNRT

NON-FINAL ACTION WRITTEN

05/10/2012

DOCK

ASSIGNED TO EXAMINER

05/09/2012

MPMK

NOTICE OF PSEUDO MARK MAILED

02/04/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/03/2012

NWAP

NEW APPLICATION ENTERED

02/03/2012

Continuous trademark protection

Get notified about every new filing that threatens ARCUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.